TELA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
19.3M
+1.2%
19.1M
-8.7%
20.9M
+0.9%
20.7M
+2.4%
20.2M
Cost of Revenue
5.3M
-18.2%
6.5M
-8.1%
7.1M
+5.9%
6.7M
+10.3%
6.1M
Gross Profit
13.9M
+11.4%
12.5M
-9.0%
13.8M
-1.5%
14.0M
-1.0%
14.1M
Operating Expenses
23.2M
+0.8%
23.0M
+13.0%
20.4M
-5.2%
21.5M
-7.2%
23.2M
R&D
2.7M
+16.2%
2.3M
+10.1%
2.1M
-9.3%
2.3M
+6.6%
2.2M
SG&A
20.5M
-1.0%
20.7M
+13.3%
18.3M
-4.7%
19.2M
-8.6%
21.0M
Operating Income
-9283000
+11.8%
-10526000
-58.3%
-6648000
+12.0%
-7554000
+16.8%
-9081000
EBITDA
-9017000
+12.1%
-10262000
-59.8%
-6423000
+12.1%
-7306000
+17.1%
-8811000
Net Income
-11262000
+8.2%
-12273000
-35.7%
-9041000
-5.1%
-8603000
+13.3%
-9923000
EPS (Basic)
$-0.20
+4.8%
$-0.21
-23.5%
$-0.17
+10.5%
$-0.19
+13.6%
$-0.22
EPS (Diluted)
$-0.20
+4.8%
$-0.21
-23.5%
$-0.17
+10.5%
$-0.19
+13.6%
$-0.22
Shares (Diluted)
57.4M
+0.3%
57.3M
+10.7%
51.7M
+13.9%
45.4M
+0.1%
45.4M
TELA Bio (TELA) โ€” Financials